SCHEMBL20257532

SCHEMBL20257532

C/C=C(\C)N(C)C[C@@H]1COC(C)(C)O1

nearest known ligand 0.38

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CA2 P00918 2/20 0.38
TMEM97 Q5BJF2 2/20 0.32
SIGMAR1 Q99720 2/20 0.32
ALDH1A1 P00352 2/20 0.32
NPSR1 Q6W5P4 1/20 0.32
KDM4E B2RXH2 1/20 0.30
MEN1 O00255 1/20 0.30
TP53 P04637 1/20 0.30
CYP3A4 P08684 1/20 0.30
MAPT P10636 1/20 0.30
PKM P14618 1/20 0.30
HPGD P15428 1/20 0.30
ALOX15 P16050 1/20 0.30
MAPK1 P28482 1/20 0.30
CASP1 P29466 1/20 0.30
BLM P54132 1/20 0.30
KMT2A Q03164 1/20 0.30
SMN1; SMN2 Q16637 1/20 0.30
HSD17B10 Q99714 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3197652 0.78 CA2 (0.38) CA2TMEM97SIGMAR1ALDH1A1NPSR1
SCHEMBL20746467 0.77 CA2 (0.44) CA2TMEM97SIGMAR1ALDH1A1NPSR1
SCHEMBL20746489 0.77 CA2 (0.44) CA2TMEM97SIGMAR1ALDH1A1NPSR1
SCHEMBL6245418 0.77 CA2 (0.44) CA2TMEM97SIGMAR1ALDH1A1NPSR1
SCHEMBL3194829 0.76 CA2 (0.39) CA2TMEM97SIGMAR1ALDH1A1NPSR1
SCHEMBL22225663 0.73 CA2 (0.41) CA2TMEM97SIGMAR1ALDH1A1NPSR1
SCHEMBL8367145 0.72 CA2 (0.39) CA2TMEM97SIGMAR1ALDH1A1NPSR1
SCHEMBL22882715 0.71 CA2 (0.44) CA2TMEM97SIGMAR1ALDH1A1NPSR1
SCHEMBL16542564 0.71 CA2 (0.44) CA2TMEM97SIGMAR1ALDH1A1NPSR1
SCHEMBL12847648 0.71 CA2 (0.44) CA2TMEM97SIGMAR1ALDH1A1NPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180162842-A1 MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS VERTEX PHARMACEUTICALS INCORPORATED 2018-06-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180162842-A1 MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS CFTR, ABCB1, ABCC2 CA2 2791/4885TMEM97 131/4885SIGMAR1 2137/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.